Leeds General Infirmary — Leeds

Public research footprint of Leeds General Infirmary, compiled from the ClinicalTrials.gov public registry.

218

Registered studies

Active

Recruiting now

122

Completed

Stopped or withdrawn

Most-studied conditions

Heart Failure With Preserved Ejection Fraction (HFpEF) · Sedation in Intensive Care Unit Patients · Spinal Muscular Atrophy Type 2 · Duchenne Muscular Dystrophy (DMD)

Recently updated registry entries

NCT06678841 — ELEVATE-HFpEF Clinical Study (Recruiting)
NCT03363373 — Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or… (Active Not Recruiting)
NCT07733986 — Exercise Therapy for Women With ANOCA (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Leeds General Infirmary?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.